ad image

Coronavirus

1 / 2
COVID-19: Understanding the Virus, the Pandemic, and the Path Forward
Coping with COVID-19

COVID-19: Understanding the Virus, the Pandemic, and the Path Forward

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

PAP-Q2-20-NI-004Jul 01, 2020
COVID-19: A Look at the Virus, its Epidemiology, Therapeutic and Vaccine Development Efforts and Impacts of the Pandemic
COVID-19

COVID-19: A Look at the Virus, its Epidemiology, Therapeutic and Vaccine Development Efforts and Impacts of the Pandemic

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

PAO-Q2-20-NI-001Apr 07, 2020
Johnson & Johnson
Vaccine

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19

Johnson & Johnson

PR-M03-20-NI-045Mar 31, 2020
Thermo Fisher Scientific
COVID-19

Thermo Fisher Scientific Receives CE Mark for its Diagnostic Test to Detect COVID-19

Thermo Fisher Scientific

PR-M03-20-NI-046Mar 31, 2020
U.S. Food & Drug Administration
FDA

FDA Expedites Review of Diagnostic Tests to Combat COVID-19

U.S. Food & Drug Administration

PR-M03-20-NI-043Mar 31, 2020
Mylan
M&A

Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn

Mylan

PR-M03-20-NI-041Mar 26, 2020
Ford Works With 3M, GE, UAW to Speed Production of Respirators for Healthcare Workers, Ventilators for Coronavirus Patients
Medical Device Production

Ford Works With 3M, GE, UAW to Speed Production of Respirators for Healthcare Workers, Ventilators for Coronavirus Patients

PR-M03-20-NI-040Mar 25, 2020
Yourway
Supply Chain

Yourway – The Biopharma Services Company – Keeps Up With Covid-19, Providing Direct-to-Patient (DTP) Services Globally

Yourway

PR-M03-20-NI-035Mar 24, 2020
BioNTech
Vaccine

Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine

BioNTech

PR-M03-20-NI-031Mar 20, 2020
GE Healthcare Increases Production to Aid Coronavirus Patients
Supply Chain

GE Healthcare Increases Production to Aid Coronavirus Patients

Nice Insight

PR-M03-20-NI-033Mar 20, 2020
Bellerophon
FDA

FDA Grants Bellerophon Emergency Expanded Access for INOpulse® for the Treatment of COVID-19 Virus

Bellerophon

PR-M03-20-NI-032Mar 20, 2020
Roche
COVID-19

Roche Initiates Phase III Clinical Trial of Actemra/RoActemra in Patients with Severe COVID-19 Pneumonia

Roche

PR-M03-20-NI-030-1678Mar 19, 2020
U.S. Food & Drug Administration
FDA

FDA Postpones Domestic Inspections Due to COVID-19 Outbreak

U.S. Food & Drug Administration

PR-M03-20-NI-028Mar 19, 2020
Roche

Roche Ships 400,000 Coronavirus Test Kits to U.S.

Roche

PR-M03-20-NI-027Mar 17, 2020
Johnson & Johnson
Coronavirus

J&J Cites Lack of Evidence for HIV Treatment Against COVID-19

Johnson & Johnson

PR-M03-20-NI-026Mar 17, 2020
Moderna
Coronavirus

Moderna Announces First Participant Dosed in Phase 1 Study of mRNA Vaccine Against Novel Coronavirus

Moderna

PR-M03-20-NI-025Mar 17, 2020
Pneumagen
Coronavirus

Pneumagen Ltd Leverages its Novel Glycan Approach to Target Coronavirus (COVID-19) Infections

Pneumagen

PR-M03-20-NI-024Mar 17, 2020
CureVac AG
Leadership

Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG

CureVac AG

PR-M03-20-NI-023Mar 12, 2020
U.S. Food & Drug Administration
Coronavirus

FDA Postpones Foreign Inspections Due to Coronavirus Outbreak

U.S. Food & Drug Administration

PR-M03-20-NI-022Mar 12, 2020
Eli Lilly and Company
Coronavirus

Lilly Statement on Novel Coronavirus and the Reliable Supply of the Company's Medicines

Eli Lilly and Company

PR-M03-20-NI-020Mar 12, 2020
1 / 2